Insiders · TTRX

TTRX insider transactions

Turn Therapeutics Inc. (TTRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for TTRX

• 23d
  SEC Form 4 filed by Burnam Bradley Evan

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 23d
  SEC Form 4 filed by Golden Arthur F

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 23d
  SEC Form 4 filed by Burnam Bradley Evan

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 23d
  SEC Form 4 filed by Chaudhary Zuraiz

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 81d
  Director Dewhurst Martin William was granted 21,882 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 81d
  SEC Form 3 filed by new insider Dewhurst Martin William

  3 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 134d
  Officer Chaudhary Zuraiz bought $8,750 worth of shares (2,500 units at $3.50), increasing direct ownership by 25% to 12,500 units (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 151d
  Director Golden Arthur F bought $33,946 worth of shares (9,868 units at $3.44), increasing direct ownership by 19% to 60,602 units (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 155d
  Officer Chaudhary Zuraiz bought $7,074 worth of shares (2,450 units at $2.89), increasing direct ownership by 32% to 10,000 units (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 159d
  Officer Chaudhary Zuraiz bought $9,050 worth of shares (2,500 units at $3.62), increasing direct ownership by 50% to 7,550 units (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 178d
  Board Observer Chesed Abraham bought $65,716 worth of shares (14,286 units at $4.60) (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 184d
  Officer Chaudhary Zuraiz bought $24,998 worth of shares (5,050 units at $4.95) (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 184d
  Director Golden Arthur F bought $100,000 worth of shares (20,202 units at $4.95), increasing direct ownership by 202% to 30,202 units (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Chief Medical Officer Ghodadra Neilesh Shailesh was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Director Kester Kent Edward was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  SEC Form 4 filed by Officer Chaudhary Zuraiz

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Director Golden Arthur F was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Director Gengos Andrew was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)